All News
Phases preceding RA diagnosis.
@karen_kc123 @RheumNow #RNL2022 https://t.co/KJT9ml8ZJY
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Completed early RA prevention trial!
One dose of Rituximab at day zero in the PRAIRI Trial, delayed onset of RA diagnosis.
After 36 months mo difference .
@karen_kc123 @RheumNow #RNL2022 https://t.co/R3639V6b07
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Patient-centered, holistic approach in #multimorbidity management.
🔑 Patients with #RA and #MM need help and coaching in guiding and directing their care.
🔑 Good communication with healthcare provider is the key.
@RheumNow #RNL2022 https://t.co/iLrZAT0y9r
Elena MyasoedovaMD MyasoedovaElena ( View Tweet)
Approaching comorbidities!
Elena Myasoedova @RheumNow #RNL2022 https://t.co/Y3JNsBT9bJ
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Thanks for coming to RheumNow Live! We'll see you next year! #RNL2022
Dr. John Cush RheumNow ( View Tweet)
"Remember bony growth is a feature of the PsA joint and one potential way in which IL17s may target the disease." Dr. B. Kirkham discusses potential synergistic activity of IL17A and TNFi in the SpA joint. #RNL2022 @RheumNow https://t.co/L9uZqoen2w
Dr. Rachel Tate uptoTate ( View Tweet)
"Instead of using the term moderate to severe PsO, I use systemic treatment eligible PsO," when thinking about medications for PsO patients. Dr. B. Strober. #RNL2022 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
Do you use Otezla with biologics in PsA? #RNL2022 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
IL-17i -
Good Long term safety profile and low malignancy risk
Best efficacy for nail psoriasis
@RheumNow #RNL2022 https://t.co/8T7wAGJChF
Robert B Chao, MD doctorRBC ( View Tweet)
"The most important thing to consider is what is the risk of PsO on the overall health (of the patient.)" BSA > 10% showed increase all cause mortality rates in IHOPE study. Dr. K. Gordon discusses PsO treatment complexity and importance at #RNL2022 @RheumNow https://t.co/ouHPbLmlqD
Dr. Rachel Tate uptoTate ( View Tweet)
Have you seen the MTX data regarding PsO? Dr. Gordon reviews the METOP data. My take homes: MTX has moderate efficacy and takes a long time! #RNL2022 @RheumNow https://t.co/B28onPUKn8
Dr. Rachel Tate uptoTate ( View Tweet)
Excellent charts presented by Dr. Kenneth Gordon on the PASI response and QoL response amongst different PsO therapies
@RheumNow #RNL2022 https://t.co/e3gqcPzk79
Robert B Chao, MD doctorRBC ( View Tweet)
How to treat #psoriasis #PsO Indivualize for pt. OK to try more than one drug within a class if initial fails or isn’t tolerated. Common I think to have 2ndary loss of response even with dose escalation. Skin is sneaky immunologically! #RNL2022 @RheumNow https://t.co/pFPNCVLSvk
Janet Pope Janetbirdope ( View Tweet)
#ClinicalPearl Fun fact According to Dr Strober IL17i have BEST effects on nail involvement in #psoriasis. I didn’t know. often need ⬆️dose over time #RNL2022 @RheumNow https://t.co/Y9U9c4M03j
Janet Pope Janetbirdope ( View Tweet)
Current treatment paradigm for PsO
@RheumNow #RNL2022 https://t.co/yDc3Pk0RjI
Robert B Chao, MD doctorRBC ( View Tweet)
Great feedback on @Janetbirdope presentation. #RNL2022
“thank you so much Dr. Pope. wish you had more time because the presentation was so applicable to clinical practice”
We are so glad you enjoyed!
Dr. John Cush RheumNow ( View Tweet)
ACPA is a strong predictor for RA development.
any ACPA : 30% developed RA within 3 years.
High titer ACPA: 50% developed RA with 3 years.
Finally ACPA Titer Matters?!
@karen_kc123 @RheumNow #RNL2022 https://t.co/blbVovf1KZ
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Healthy behaviors (moderate EtOH, healthy body weight, no smoking, healthy diet, physical activity) associated with lower RA risk
"Chronic systemic inflammation fans the flames of brewing RA"
@RheumNow #RNL2022 https://t.co/gAerZaAcso
Robert B Chao, MD doctorRBC ( View Tweet)
Family history risk includes genetic and shared environmental factors
@RheumNow #RNL2022 https://t.co/3J4nisbSX1
Robert B Chao, MD doctorRBC ( View Tweet)
ACPA prior to RA diagnosis.
Notice epitope spreading proceeding diagnosis!!
@karen_kc123 @RheumNow #RNL2022 https://t.co/glgrOdVyyJ
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)